Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
By W. Marks, R. Bartus, J. Siffert, C. S. Davis, A. Lozano, N. Boulis, J. Vitek, M. Stacy, Dennis A. Turner, L. Verhagen and 16 more. Lancet Neurology, 2010
618 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/10a57f5f55b1d76f788e176937b320f175616fe6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
Citations in the corpus
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease (2011, background): “Unfortunately, this preclinical success has not been recapitulated in clinical trials where intraputaminal delivery of AAV-mediated neurturin failed to show efficacy (Marks et al., 2010).”